The trajectory of Viagra presents a complex picture for shareholders. While the initial launch generated massive returns, the expiration of its patent opened the door to generic competitors, dramatically diminishing https://bookmarkforest.com/story21557166/viagra-and-big-pharma-a-risky-investment